200,000 highly purified CD19+ve B cells isolated from the peripheral blood of each of 14 newly diagnosed treatment-naïve seropositive early rheumatoid arthritis (ERA) patients (cohort 1/Supplementary Table 1) and 16 healthy controls were sequenced by NGS. This evidence concerns the gene CD19 and enthesitis-related juvenile idiopathic arthritis.